Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Celestite 6x
Generic Name
Celestite 6x
Active Ingredient
StrontiumCategory
Calcium [EPC]
Salt Form
Bromide
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 6 [hp_X]/30mL | LIQUID | ORAL | 53645-1901 |
Detailed information about Celestite 6x
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Celestite 6x, you must consult a qualified healthcare professional.
Strontium is an alkaline earth metal chemically similar to calcium. While historically used as a bromide salt for sedation, modern applications focus on bone density management and radiopharmaceutical therapy.
Dosage for strontium varies significantly based on the salt form and the condition being treated. Because strontium is often used as a supplement or in specialized radiopharmaceutical applications, there is no single 'standard' dose.
Strontium is generally not approved for use in children. Because strontium is incorporated into the bone matrix, there are significant concerns regarding its impact on the developing skeleton and growth plates of pediatric patients. Exposure to high levels of strontium in childhood can lead to 'strontium rickets,' a condition where the bones fail to mineralize properly. Unless specifically directed by a pediatric specialist in a controlled clinical setting, strontium should be avoided in patients under the age of 18.
Strontium is primarily cleared by the kidneys. In patients with mild to moderate renal impairment (Creatinine Clearance 30-70 mL/min), caution is advised. In patients with severe renal impairment (Creatinine Clearance less than 30 mL/min), strontium is generally contraindicated. The risk of systemic accumulation and potential toxicity is significantly higher when kidney function is compromised.
Since strontium does not undergo hepatic metabolism, dosage adjustments based solely on liver function are typically not required. However, many patients with liver disease also have secondary renal issues, which must be evaluated.
No specific dosage adjustment is required for the elderly based on age alone; however, this population is at higher risk for undiagnosed renal impairment. Healthcare providers should assess kidney function (e.g., eGFR) before initiating strontium therapy in older adults.
To ensure maximum efficacy and safety, strontium must be taken with specific attention to timing and diet:
If you miss a dose of strontium, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up. Because strontium has a long half-life in the bone, a single missed dose is unlikely to have an immediate impact on treatment outcomes, but consistency is key for long-term bone health.
Signs of acute strontium overdose may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally supportive, focusing on maintaining hydration and, in severe cases, using diuretics or dialysis to facilitate the removal of strontium from the blood.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Strontium can stay in your system for a long time, so any changes to your regimen should be managed by a professional.
Strontium is generally well-tolerated when taken at recommended doses, but some patients may experience gastrointestinal or neurological symptoms. Common side effects include:
> Warning: Stop taking Strontium and call your doctor immediately if you experience any of these:
Currently, strontium supplements (like strontium citrate) do not carry FDA Black Box Warnings because they are marketed as dietary supplements rather than drugs. However, the European Medicines Agency (EMA) previously issued severe restrictions for strontium ranelate (Protelos) due to the risk of serious cardiovascular events and blood clots. Healthcare providers are advised to screen patients for a history of heart disease or circulatory issues before recommending strontium.
Report any unusual symptoms to your healthcare provider. Your doctor may perform periodic blood tests to monitor your mineral levels and kidney function while you are taking strontium.
Strontium is a potent mineral that significantly alters bone physiology. It is not a simple 'vitamin' and must be treated with clinical caution. Patients must be aware that strontium can permanently alter the results of bone density tests (DEXA scans). Because strontium atoms are heavier than calcium atoms, they attenuate X-rays more effectively, leading to an overestimation of bone mineral density by as much as 10% to 50%. This can give a false sense of security regarding bone strength.
No FDA black box warnings for Strontium are currently active in the United States, as the FDA has not approved strontium ranelate for the treatment of osteoporosis. However, medical professionals often look to international data, such as the EMA’s warnings regarding Cardiovascular Risk and Venous Thromboembolism (VTE). These warnings state that strontium should not be used in patients with a history of ischemic heart disease, peripheral arterial disease, cerebrovascular disease, or uncontrolled hypertension.
If you are taking strontium long-term, your healthcare provider may require the following:
Strontium may cause dizziness, fainting, or headaches in some individuals, particularly during the first few weeks of treatment. If you experience these side effects, do not drive or operate heavy machinery until you are certain the medication does not impair your ability to perform these tasks safely.
There is no direct chemical interaction between strontium and alcohol. However, excessive alcohol consumption is a known risk factor for both osteoporosis and falls. Furthermore, alcohol can exacerbate the gastrointestinal side effects (nausea/diarrhea) associated with strontium. It is generally recommended to limit alcohol intake while being treated for bone density issues.
Strontium does not typically cause a 'withdrawal syndrome.' However, because it has a very long half-life in the bone, its effects (and side effects) may persist for months or even years after the last dose is taken. If you need to stop strontium due to an upcoming surgery or a serious side effect, consult your doctor for a management plan.
> Important: Discuss all your medical conditions with your healthcare provider before starting Strontium, especially if you have a history of heart attack, stroke, or blood clots.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is essential to avoid treatment failure or toxicity.
Strontium must NEVER be used in the following circumstances:
In these cases, a healthcare provider must perform a careful risk-benefit analysis:
There is no documented cross-sensitivity between strontium and common allergens like penicillin or sulfa drugs. However, patients who have had severe reactions to other divalent metal supplements (like calcium or magnesium formulations) should be monitored for similar gastrointestinal or dermatological sensitivities.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Strontium. Ensure you disclose all past cardiovascular and renal issues.
Strontium is generally not recommended during pregnancy. It is classified by many authorities as a substance with potential fetal risk. Because strontium mimics calcium, it readily crosses the placental barrier and is deposited into the developing skeleton of the fetus. While the long-term effects on human infants are not fully understood, animal studies have shown that high levels of strontium can interfere with normal bone mineralization and lead to skeletal abnormalities. If a patient becomes pregnant while taking strontium, the medication should be discontinued immediately, and a healthcare provider should be consulted.
Strontium is excreted into human breast milk. Because of its long half-life and its ability to be incorporated into the bone of a nursing infant, the use of strontium while breastfeeding is generally discouraged. There is a theoretical risk that the infant could absorb enough strontium to affect their own bone development. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
As previously noted, strontium is contraindicated in children and adolescents. The primary concern is the interference with the growth plates (epiphyses). In developing children, strontium can replace calcium in the newly forming bone, leading to a softer bone matrix and a condition known as 'strontium rickets.' This can cause permanent bowing of the legs and other skeletal deformities. Strontium should only be used in pediatric cases involving rare metabolic disorders under the strictest specialist supervision.
While strontium is often used in the elderly to treat osteoporosis, this population requires the most careful monitoring. Geriatric patients are more likely to have:
Renal function is the 'gatekeeper' for strontium safety.
Strontium is not effectively removed by standard hemodialysis, meaning an overdose in a renal patient is difficult to treat.
There are no specific guidelines for strontium use in patients with liver disease, as the liver does not play a role in its clearance. However, patients with advanced cirrhosis often develop 'hepatorenal syndrome' (kidney failure caused by liver failure). In such cases, the renal contraindications would apply.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or have any history of kidney or heart disease.
Strontium acts as a 'calcium mimetic' with a unique dual effect on bone metabolism. It functions as an agonist at the Calcium-Sensing Receptor (CaSR). When strontium binds to these receptors on the surface of osteoblasts, it activates intracellular signaling pathways (such as the MAPK/ERK pathway) that promote the proliferation and differentiation of bone-building cells. This leads to increased synthesis of collagen and bone matrix.
Simultaneously, strontium acts on osteoclasts. By stimulating the CaSR on these bone-resorbing cells, it induces apoptosis (programmed cell death) and inhibits their activity. It also modulates the RANKL/OPG ratio. By increasing the production of Osteoprotegerin (OPG) and decreasing RANKL, strontium further prevents the maturation of new osteoclasts. This results in a net shift toward bone formation.
The onset of strontium's effect on bone mineral density is slow, typically requiring 3 to 6 months of daily use before significant changes are measurable. The duration of effect is exceptionally long; because strontium is incorporated into the hydroxyapatite crystals, it remains in the body until that specific unit of bone is remodeled, which can take years. There is no evidence of tolerance development, but the cardiovascular risks appear to be cumulative over time.
| Parameter | Value |
|---|---|
| Bioavailability | 25% - 30% |
| Protein Binding | < 25% |
| Half-life (Plasma) | ~60 hours |
| Half-life (Bone) | Several years |
| Tmax (Time to Peak) | 3 - 5 hours |
| Metabolism | None (Elemental) |
| Excretion | Renal (60%), Fecal (40%) |
Strontium is classified as a Bone Modulating Agent and falls under the Calcium [EPC] category in the FDA's pharmacological classification. It is related to other bone-seeking elements like Radium and Calcium, and its therapeutic use in osteoporosis is often compared to bisphosphonates and SERMs (Selective Estrogen Receptor Modulators), although its mechanism is distinct from both.
Common questions about Celestite 6x
Strontium is primarily used to support bone health and treat conditions like osteoporosis, though its use varies by country and salt form. In Europe, strontium ranelate is a prescription medication used to reduce the risk of fractures in postmenopausal women. In the United States, strontium is more commonly found as a dietary supplement (strontium citrate) intended to increase bone mineral density. Additionally, a radioactive form called Strontium-89 is used in oncology to relieve bone pain caused by cancer that has spread to the skeleton. Historically, strontium bromide was used as a sedative and treatment for epilepsy, though this is now obsolete. Always consult a healthcare provider to see if strontium is appropriate for your specific medical needs.
The most frequently reported side effects of strontium include gastrointestinal issues such as nausea, diarrhea, and abdominal discomfort. These symptoms are usually mild and often resolve after the first few weeks of treatment as the body adjusts. Some patients also report headaches or mild skin irritation and itching. More serious but less common side effects include an increased risk of blood clots (venous thromboembolism) and cardiovascular events like heart attacks. Rare but severe allergic reactions, such as DRESS syndrome, have also been documented. Because of these risks, any new or unusual symptoms should be reported to a doctor immediately.
There is no known direct chemical interaction between strontium and alcohol that would cause immediate danger. However, healthcare providers generally recommend limiting alcohol intake when treating bone conditions like osteoporosis. Chronic alcohol consumption can interfere with calcium absorption and bone formation, potentially neutralizing the benefits of strontium therapy. Furthermore, alcohol can worsen the nausea and dizziness that some people experience when starting strontium. To maximize the effectiveness of your treatment and ensure your safety, it is best to discuss your alcohol consumption habits with your physician.
Strontium is generally considered unsafe for use during pregnancy and should be avoided. Because strontium is chemically similar to calcium, it easily crosses the placenta and is incorporated into the developing fetus's bones. Animal studies suggest that this can lead to skeletal abnormalities and impaired bone mineralization in the offspring. There is also a lack of controlled clinical trials in pregnant humans to prove its safety. If you are pregnant or planning to become pregnant, you should not take strontium unless specifically instructed by a specialist who has weighed the significant risks. Always use effective contraception while on strontium therapy if you are of childbearing age.
Strontium is not a fast-acting medication; it works gradually by altering the balance of bone remodeling. While some biochemical markers of bone formation may change within a few weeks, it typically takes 3 to 6 months of consistent daily use to see a measurable increase in bone mineral density (BMD). For the treatment of bone pain using radioactive Strontium-89, relief may begin within 7 to 14 days after the injection and can last for several months. For bone density purposes, the full protective effect against fractures may not be realized until after a year or more of continuous treatment. Patience and adherence to the prescribed regimen are essential for success.
Stopping strontium suddenly does not typically cause immediate withdrawal symptoms or a 'rebound' effect. However, because strontium has an extremely long half-life and stays in the bone matrix for years, its effects on your bone density and your DEXA scan results will persist long after you stop taking it. If you are stopping the medication because of a side effect like a rash or a blood clot, you should do so immediately and contact your doctor. If you are stopping for other reasons, your bone density may gradually begin to decline back to its baseline over several years. Always inform your healthcare provider before stopping any long-term medication.
If you miss a dose of strontium, you should take it as soon as you remember, provided it is not too close to your next scheduled dose. If it is almost time for your next dose, simply skip the missed one and continue with your regular schedule. Do not take two doses at once to make up for the one you missed, as this can increase the risk of gastrointestinal upset. Because strontium builds up in the bone over a very long period, a single missed dose will not significantly impact the overall success of your treatment. Consistency is important, so try to take your dose at the same time each day, preferably at bedtime.
Weight gain is not a commonly reported side effect of strontium in clinical trials or post-marketing surveillance. Strontium does not appear to affect metabolism, appetite, or fat storage in a way that would lead to significant changes in body weight. However, some patients may experience bloating or peripheral edema (swelling in the legs), which could be perceived as weight gain. If you notice a rapid or unexplained increase in weight while taking strontium, it is important to contact your healthcare provider. This could be a sign of a more serious underlying issue, such as heart or kidney problems, rather than a direct effect of the mineral itself.
Strontium has several significant drug interactions that require careful management. It should not be taken at the same time as calcium supplements, antacids, or dairy products, as these will prevent the strontium from being absorbed properly. It also interferes with the absorption of certain antibiotics, such as tetracyclines and quinolones, which can make them less effective at fighting infections. If you must take these medications, they should be spaced at least two to four hours apart from your strontium dose. Always provide your doctor with a full list of all prescription drugs, over-the-counter medicines, and herbal supplements you are using to avoid dangerous interactions.
Strontium is available in several forms, many of which are sold as generic dietary supplements. Strontium citrate and strontium chloride are widely available over-the-counter without a brand name. However, strontium ranelate (the form most studied for osteoporosis) was originally a branded product (Protelos) and may not be available as a generic in all regions. In the United States, because strontium is not FDA-approved as a drug for osteoporosis, 'generic' versions are essentially unregulated supplements. It is important to choose a reputable manufacturer and consult with a healthcare professional to ensure the product you are using is safe and contains the amount of strontium stated on the label.
Other drugs with the same active ingredient (Strontium)